Implementation deadlines

IMPLEMENTATION SCHEDULE

 

 

  • June 2016 : For new marketing authorization

​​​

 

  • December 2017 : For products already marketed

 

 

 

CURRENT REGULATION

The ICH Q3D guideline comes into effect in the three pharmacopeias (Europe, US and Japan).                                                                                                                                                                                                             

USP -232- ELEMENTAL IMPURITIES LIMITS 
USP -233- ELEMENTAL IMPURITIES PROCEDURES

JP 1.07 "HEAVY METALS LIMIT TEST"
PH. EUR: 5.20, 2.4.20, 2.4.8

 

 

 

To fullfill ICH Q3D requirements before this deadlines expired, we develop Elemental Impurities Implementation of Risk Assessment Reports, for both API manufacturers and drug product manufacturers. You can contact us regarding a QUOTATION REQUEST for an ICH Q3D report development.

Latest news

A3P Cleaning Validation Symposium 2022

Next March 16th and 17th 2022, Socosur Tox will exhibit at the new edition of the A3P...(...)

JP Morgan 40th Annual Healthcare Conference

Socosur will attend JP Morgan 2022, especially in the light of upcoming announcements  ...(...)

Best wishes for 2022

Happy New Year 2022 to you all! Thanks you again to you for your confidence in Socosur along...(...)

Back to physical CPhI 2021

SOCOSUR WILL BE BACK TO CPHI WITH BOOTH LOCATED 14B61   CPhI Worldwide houses six...(...)

Stay in touch